Robert Langreth reports:
Unless more is done about a wave of new and expensive drugs, some priced at as much as $50,000 a month, Miller [the chief medical officer at Scripts Express] says that health plans are going to be swamped as costs double to half a trillion dollars as soon as 2020. […]
Drug companies that “think they can charge whatever they want” in competitive categories “run the risk of being excluded,” said Glen Stettin, 50, Miller’s colleague responsible for clinical products, including formularies.
Correction: In my first draft, I had written that CVS will keep 95% of drugs, not 95 drugs, off its main formulary. My bad.